Use of serological surveys to generate key insights into the changing global landscape of infectious disease.
作者信息
Metcalf C Jessica E, Farrar Jeremy, Cutts Felicity T, Basta Nicole E, Graham Andrea L, Lessler Justin, Ferguson Neil M, Burke Donald S, Grenfell Bryan T
机构信息
Department of Ecology and Evolutionary Biology, Princeton University, Princeton, NJ, USA; Fogarty International Center, National Institute of Health, Bethesda, MD, USA.
Wellcome Trust, Gibbs Building, London, UK.
出版信息
Lancet. 2016 Aug 13;388(10045):728-30. doi: 10.1016/S0140-6736(16)30164-7. Epub 2016 Apr 5.
Abstract
摘要
相似文献
1
Use of serological surveys to generate key insights into the changing global landscape of infectious disease.
Lancet. 2016 Aug 13;388(10045):728-30. doi: 10.1016/S0140-6736(16)30164-7. Epub 2016 Apr 5.
2
[Diagnosis of parasite infections. Significance of serological examinations].
Internist (Berl). 2006 Aug;47(8):786, 788-90, 792. doi: 10.1007/s00108-006-1654-3.
3
Serological epidemiology and the function of serum banks.
Arch Gesamte Virusforsch. 1965;17(3):465-71. doi: 10.1007/BF01241202.
4
Integrated Serologic Surveillance of Population Immunity and Disease Transmission.
Emerg Infect Dis. 2018 Jul;24(7):1188-1194. doi: 10.3201/eid2407.171928.
5
Deciphering serology to understand the ecology of infectious diseases in wildlife.
Ecohealth. 2013 Sep;10(3):298-313. doi: 10.1007/s10393-013-0856-0. Epub 2013 Aug 6.
6
[Clinical value of infectious agents-specific antibodies].
Zhonghua Er Ke Za Zhi. 2020 Apr 2;58(4):343-345. doi: 10.3760/cma.j.cn112140-20200303-00169.
7
[Serologic tests and detection of microbial antigens for diagnosis of infectious diseases].
Rinsho Byori. 2003 Feb;Suppl 124:32-8.
8
Are IgG antibody avidity assays useful in the diagnosis of infectious diseases? A review.
Microbios. 1996;87(351):113-21.
9
Operative performances and efficiency for infectious disease testing of two immunochemistry analyzers--Abbott ARCHITECT i2000SR and DiaSorin Liaison XL.
Clin Chem Lab Med. 2015 Jan;53(1):e19-23. doi: 10.1515/cclm-2014-0499.
10
Estimation of effective reproduction numbers for infectious diseases using serological survey data.
Biostatistics. 2003 Oct;4(4):621-32. doi: 10.1093/biostatistics/4.4.621.
引用本文的文献
1
Role and Contribution of Serological Surveillance in Animals and Exposed Humans to the Study of Zoonotic Influenza Disease Epidemiology: A Scoping Review.
Pathogens. 2025 Jul 27;14(8):739. doi: 10.3390/pathogens14080739.
2
Serological survey to determine measles and rubella immunity gaps across age and geographic locations in The Gambia: a study protocol.
Glob Health Action. 2025 Dec;18(1):2540135. doi: 10.1080/16549716.2025.2540135. Epub 2025 Aug 20.
3
Using COVID-19 pandemic perturbation to model RSV-hMPV interactions and potential implications under RSV interventions.
Nat Commun. 2025 Aug 6;16(1):7261. doi: 10.1038/s41467-025-62358-w.
4
The Mathematics of Serocatalytic Models With Applications to Public Health Data.
Stat Med. 2025 Jul;44(15-17):e70188. doi: 10.1002/sim.70188.
5
Granular Insights:A Wastewater-Based Machine Learning Approach for Localized COVID-19 Hospitalization Forecasting.
medRxiv. 2025 Jun 26:2025.06.25.25330294. doi: 10.1101/2025.06.25.25330294.
6
Feasibility of blood self-sampling with HemaSpot HF for Anti-Clostridium tetani Toxin IgG detection.
Sci Rep. 2025 Jul 3;15(1):23693. doi: 10.1038/s41598-025-06674-7.
7
Profile: The Kenya Multi-Site Serosurveillance (KEMIS) collaboration.
Gates Open Res. 2025 Feb 27;8:60. doi: 10.12688/gatesopenres.15569.2. eCollection 2024.
8
The Use of Residual Blood Specimens in Seroprevalence Studies for Vaccine-Preventable Diseases: A Scoping Review.
Vaccines (Basel). 2025 Mar 18;13(3):321. doi: 10.3390/vaccines13030321.
9
Overcoming Health Inequities: Spatial Analysis of Seroprevalence and Vaccination Against COVID-19 in Chile.
Health Equity. 2024 Aug 26;8(1):558-567. doi: 10.1089/heq.2023.0204. eCollection 2024.
10
High-throughput multiplexed serology via the mass-spectrometric analysis of isotopically barcoded beads.
Nat Biomed Eng. 2025 Feb 12. doi: 10.1038/s41551-025-01349-0.
本文引用的文献
1
Population-level antibody estimates to novel influenza A/H7N9.
J Infect Dis. 2013 Aug 15;208(4):554-8. doi: 10.1093/infdis/jit224. Epub 2013 May 17.
2
Measuring coverage in MNCH: design, implementation, and interpretation challenges associated with tracking vaccination coverage using household surveys.
PLoS Med. 2013;10(5):e1001404. doi: 10.1371/journal.pmed.1001404. Epub 2013 May 7.
3
Development of a new platform for neglected tropical disease surveillance.
Int J Parasitol. 2012 Aug;42(9):797-800. doi: 10.1016/j.ijpara.2012.07.002. Epub 2012 Jul 27.
4
Evidence for antigenic seniority in influenza A (H3N2) antibody responses in southern China.
PLoS Pathog. 2012;8(7):e1002802. doi: 10.1371/journal.ppat.1002802. Epub 2012 Jul 19.
5
Epidemic and intervention modelling--a scientific rationale for policy decisions? Lessons from the 2009 influenza pandemic.
Bull World Health Organ. 2012 Apr 1;90(4):306-10. doi: 10.2471/BLT.11.097949.
6
Evolutionary genetics of human enterovirus 71: origin, population dynamics, natural selection, and seasonal periodicity of the VP1 gene.
J Virol. 2010 Apr;84(7):3339-50. doi: 10.1128/JVI.01019-09. Epub 2010 Jan 20.
7
Strategies for differentiating infection in vaccinated animals (DIVA) for foot-and-mouth disease, classical swine fever and avian influenza.
Expert Rev Vaccines. 2010 Jan;9(1):73-87. doi: 10.1586/erv.09.130.
8
A mathematical model to estimate global hepatitis B disease burden and vaccination impact.
Int J Epidemiol. 2005 Dec;34(6):1329-39. doi: 10.1093/ije/dyi206. Epub 2005 Oct 25.
9
Estimating medium- and long-term trends in malaria transmission by using serological markers of malaria exposure.
Proc Natl Acad Sci U S A. 2005 Apr 5;102(14):5108-13. doi: 10.1073/pnas.0408725102. Epub 2005 Mar 25.
10
Modelling the incidence of congenital rubella syndrome in developing countries.
Int J Epidemiol. 1999 Dec;28(6):1176-84. doi: 10.1093/ije/28.6.1176.
Zotero 插件